1,056 results on '"Muyldermans, Serge"'
Search Results
2. Epitope mapping of nanobodies binding the Alzheimer’s disease receptor SORLA
3. Orally delivered single-domain antibodies against gastrointestinal pathogens
4. Broad protection against invasive fungal disease from a nanobody targeting the active site of fungal b‐1,3‐glucanosyltransferases
5. Towards a Wearable Feminine Hygiene Platform for Detection of Invasive Fungal Pathogens via Gold Nanoparticle Aggregation
6. Instant One-Pot Green Synthesis of Functional Ultra-Stable Gold Nanoparticles: Vaginal Candidiasis Point-of-Care Case Study
7. An overview on display systems (phage, bacterial, and yeast display) for production of anticancer antibodies; advantages and disadvantages
8. Nanobodies targeting ABCC3 for immunotargeted applications in glioblastoma
9. Nanobodies as binding-chaperones stabilize the recombinant Bombyx mori acetylcholinesterase and protect the enzyme activity in pesticide detection
10. Broad Protection against Invasive Fungal Disease from a Nanobody Targeting the Active Site of Fungal β‐1,3‐Glucanosyltransferases.
11. Animal Immunization, in Vitro Display Technologies, and Machine Learning for Antibody Discovery
12. Structural basis of nanobody recognition of grapevine fanleaf virus and of virus resistance loss
13. Selection of specific nanobodies to develop an immuno-assay detecting Staphylococcus aureus in milk
14. Correction to: Llama peripheral B-cell populations producing conventional and heavy chain-only IgG subtypes are phenotypically indistinguishable but immunogenetically distinct
15. Cytoplasmic Expression of Nanobodies with Formylglycine Generating Enzyme Tag and Conversion to a Bio-Orthogonal Aldehyde Group
16. Nanobodies: From Serendipitous Discovery of Heavy Chain-Only Antibodies in Camelids to a Wide Range of Useful Applications
17. Bibliometric and scientometric analysis of PSMA-targeted radiotheranostics: knowledge mapping and global standing.
18. Towards a Wearable Feminine Hygiene Platform for Detection of Invasive Fungal Pathogens via Gold Nanoparticle Aggregation.
19. Reshaping nanobodies for affinity purification on protein a
20. Development of anti-matrix metalloproteinase-2 (MMP-2) nanobodies as potential therapeutic and diagnostic tools
21. Instant Candida albicans Detection Using Ultra-Stable Aptamer Conjugated Gold Nanoparticles
22. Structural Insights into Polymorphic ABO Glycan Binding by Helicobacter pylori
23. Development of Nanobodies against Mal de Río Cuarto virus major viroplasm protein P9-1 for diagnostic sandwich ELISA and immunodetection
24. The Therapeutic Potential of Nanobodies
25. An innovative approach in the detection of Toxocara canis excretory/secretory antigens using specific nanobodies
26. PSMA-targeted radiotheranostics in modern nuclear medicine: then, now, and what of the future?
27. Camel-Derived Nanobodies as Potent Inhibitors of New Delhi Metallo-β-Lactamase-1 Enzyme.
28. Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20
29. Llama peripheral B-cell populations producing conventional and heavy chain-only IgG subtypes are phenotypically indistinguishable but immunogenetically distinct
30. Structural evaluation of a nanobody targeting complement receptor Vsig4 and its cross reactivity
31. Limiting the protein corona: A successful strategy for in vivo active targeting of anti-HER2 nanobody-functionalized nanostars
32. Electrochemical detection of Toxocara canis excretory-secretory antigens in children from rural communities in Esmeraldas Province, Ecuador: association between active infection and high eosinophilia
33. Paradigm shift in the diagnosis of peste des petits ruminants: scoping review
34. Site-Selective Functionalization of Nanobodies Using Intein-Mediated Protein Ligation for Innovative Bioconjugation
35. Data from Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma
36. Table S4 from Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma
37. Figure S1 from Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma
38. Screening and epitope characterization of diagnostic nanobody against total and activated Bacteroides fragilis toxin
39. Site-Specific Radioactive Labeling of Nanobodies
40. Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer’s disease progression
41. Construction of High-Quality Camel Immune Antibody Libraries
42. Monitoring liver macrophages using nanobodies targeting Vsig4: Concanavalin A induced acute hepatitis as paradigm
43. Exploration of Specific Nanobodies As Immunological Reagents to Detect Milk Allergen of β-Lactoglobulin without Interference of Hydrolytic Peptides
44. Nanobodies for the Early Detection of Ovarian Cancer
45. Molecular Imaging with Kupffer Cell-Targeting Nanobodies for Diagnosis and Prognosis in Mouse Models of Liver Pathogenesis
46. Nanoimmunoassay onto a screen printed electrode for HER2 breast cancer biomarker determination
47. Single Domain Antibody application in bacterial infection diagnosis and neutralization
48. Identification of Serum Ferritin-Specific Nanobodies and Development towards a Diagnostic Immunoassay
49. Nanobodies, Single-Domain Antigen-Binding Fragments of Camelid Heavy-Chain Antibodies
50. Isolation of Antigen-Specific Nanobodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.